- Home
- SIFY vs PRTA Comparison
SIFY vs PRTA Comparison
Compare SIFY & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIFY
- PRTA
- Stock Information
- Founded
- SIFY 1995
- PRTA 2012
- Country
- SIFY India
- PRTA Ireland
- Employees
- SIFY N/A
- PRTA N/A
- Industry
- SIFY Computer Software: Programming Data Processing
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- SIFY Technology
- PRTA Health Care
- Exchange
- SIFY Nasdaq
- PRTA Nasdaq
- Market Cap
- SIFY 369.1M
- PRTA 351.5M
- IPO Year
- SIFY 1999
- PRTA N/A
- Fundamental
- Price
- SIFY $5.55
- PRTA $6.68
- Analyst Decision
- SIFY
- PRTA Buy
- Analyst Count
- SIFY 0
- PRTA 9
- Target Price
- SIFY N/A
- PRTA $27.67
- AVG Volume (30 Days)
- SIFY 72.7K
- PRTA 931.6K
- Earning Date
- SIFY 07-18-2025
- PRTA 08-07-2025
- Dividend Yield
- SIFY N/A
- PRTA N/A
- EPS Growth
- SIFY N/A
- PRTA N/A
- EPS
- SIFY N/A
- PRTA N/A
- Revenue
- SIFY $480,237,627.00
- PRTA $137,935,000.00
- Revenue This Year
- SIFY N/A
- PRTA N/A
- Revenue Next Year
- SIFY $13.46
- PRTA $122.02
- P/E Ratio
- SIFY N/A
- PRTA N/A
- Revenue Growth
- SIFY 12.82
- PRTA 54.55
- 52 Week Low
- SIFY $1.84
- PRTA $4.32
- 52 Week High
- SIFY $5.95
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- SIFY 62.11
- PRTA 58.93
- Support Level
- SIFY $4.84
- PRTA $6.24
- Resistance Level
- SIFY $5.95
- PRTA $6.94
- Average True Range (ATR)
- SIFY 0.36
- PRTA 0.28
- MACD
- SIFY 0.06
- PRTA 0.04
- Stochastic Oscillator
- SIFY 71.43
- PRTA 66.67
About SIFY Sify Technologies Limited
Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.